Disability in atypical parkinsonian syndromes is more dependent on memory dysfunction than motor symptoms

被引:7
作者
Cushing, N. [1 ,2 ]
Jang, J. [1 ,2 ]
O'Connor, C. M. [1 ,2 ]
Burrell, J. R. [1 ,2 ,3 ]
Clemson, L. [2 ]
Hodges, J. R. [1 ,3 ]
Mioshi, E. [1 ,3 ]
机构
[1] Neurosci Res Australia, Sydney, NSW 2031, Australia
[2] Univ Sydney, Fac Hlth Sci, Sydney, NSW 2006, Australia
[3] Univ New S Wales, Sch Med Sci, Sydney, NSW 2052, Australia
基金
澳大利亚国家健康与医学研究理事会; 澳大利亚研究理事会; 英国医学研究理事会;
关键词
Corticobasal syndrome; Progressive supranuclear palsy; Primary progressive aphasia-nonfluent; variant; Activities of daily living; Functional disability; Apraxia; Memory; Cognitive deficits; Behavioural changes; PROGRESSIVE SUPRANUCLEAR PALSY; ADDENBROOKES COGNITIVE EXAMINATION; CORTICOBASAL DEGENERATION; FRONTOTEMPORAL DEMENTIA; APHASIA; PATHOLOGY; DISEASE; CRITERIA; UTILITY;
D O I
10.1016/j.parkreldis.2013.01.002
中图分类号
R74 [神经病学与精神病学];
学科分类号
摘要
Background: There is a gap in the systematic description and investigation of functional disability in corticobasal syndrome (CBS) and progressive supranuclear palsy (PSP). Additionally, the relations between disability, apraxia, cognitive and behavioural changes are not well understood in atypical parkinsonian syndromes. Methods: Fifty patients were included in this study (CBS = 18; PSP = 11), including a subgroup of primary progressive aphasia-nonfluent variant (PPA-nfv = 21) who were used as a control group given the clinic-pathological overlap. Functional disability (basic and instrumental activities of daily living), general cognition and behavioural changes were evaluated at baseline, with a subgroup of patients being reassessed after 16 months. Results: The corticobasal syndrome group had the most marked disability in basic activities in comparison to progressive supranuclear palsy and primary progressive aphasia-nonfluent variant. Longitudinal decline was marked for all three groups. In a linear regression examining factors behind functional disability in CBS and PSP, memory dysfunction emerged as the main factor (48.5%), followed by apraxia (14.9%) and atypical parkinsonian symptoms (9.6%). Conclusions: Memory dysfunction is the most important factor in functional disability in CBS and PSP, which has to be taken into consideration in disease management, prognosis and planning of services to fully address patients' and families' needs. (C) 2013 Elsevier Ltd. All rights reserved.
引用
收藏
页码:436 / 440
页数:5
相关论文
共 27 条
[1]   Progressive nonfluent aphasia and subsequent aphasic dementia associated with atypical progressive supranuclear palsy pathology [J].
Boeve, B ;
Dickson, D ;
Duffy, J ;
Bartleson, J ;
Trenerry, M ;
Petersen, R .
EUROPEAN NEUROLOGY, 2003, 49 (02) :72-78
[2]   Pathologic heterogeneity in clinically diagnosed corticobasal degeneration [J].
Boeve, BF ;
Maraganore, DM ;
Parisi, JE ;
Ahlskog, JE ;
Graff-Radford, N ;
Caselli, RJ ;
Dickson, DW ;
Kokmen, E ;
Petersen, RC .
NEUROLOGY, 1999, 53 (04) :795-800
[3]   Development of a functional measure for persons with Alzheimer's disease:: The disability assessment for dementia [J].
Gélinas, I ;
Gauthier, L ;
McIntyre, M ;
Gauthier, S .
AMERICAN JOURNAL OF OCCUPATIONAL THERAPY, 1999, 53 (05) :471-481
[4]   The evolution and pathology of frontotemporal dementia [J].
Kertesz, A ;
McMonagle, P ;
Blair, M ;
Davidson, W ;
Munoz, DG .
BRAIN, 2005, 128 :1996-2005
[5]   The corticobasal degeneration syndrome overlaps progressive aphasia and frontotemporal dementia [J].
Kertesz, A ;
Martinez-Lage, P ;
Davidson, W ;
Munoz, DG .
NEUROLOGY, 2000, 55 (09) :1368-1375
[6]   Behavior and cognition in corticobasal degeneration and progressive supranuclear palsy [J].
Kertesz, Andrew ;
McMonagle, Paul .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 2010, 289 (1-2) :138-143
[7]   Clinicopathological Correlations in Corticobasal Degeneration [J].
Lee, Suzee E. ;
Rabinovici, Gil D. ;
Mayo, Mary Catherine ;
Wilson, Stephen M. ;
Seeley, William W. ;
DeArmond, Stephen J. ;
Huang, Eric J. ;
Trojanowski, John Q. ;
Growdon, Matthew E. ;
Jang, Jung Y. ;
Sidhu, Manu ;
See, Tricia M. ;
Karydas, Anna M. ;
Gorno-Tempini, Maria-Luisa ;
Boxer, Adam L. ;
Weiner, Michael W. ;
Geschwind, Michael D. ;
Rankin, Katherine P. ;
Miller, Bruce L. .
ANNALS OF NEUROLOGY, 2011, 70 (02) :327-340
[8]   Clinical research criteria for the diagnosis of progressive supranuclear palsy (Steele-Richardson-Olszewski syndrome): Report of the NINDS-SPSP International Workshop [J].
Litvan, I ;
Agid, Y ;
Calne, D ;
Campbell, G ;
Dubois, B ;
Duvoisin, RC ;
Goetz, CG ;
Golbe, LI ;
Grafman, J ;
Growdon, JH ;
Hallett, M ;
Jankovic, J ;
Quinn, NP ;
Tolosa, E ;
Zee, DS ;
Chase, TN ;
FitzGibbon, EJ ;
Hall, Z ;
Juncos, J ;
Nelson, KB ;
Oliver, E ;
Pramstaller, P ;
Reich, SG ;
Verny, M .
NEUROLOGY, 1996, 47 (01) :1-9
[9]   Randomized placebo-controlled trial of donepezil in patients with progressive supranuclear palsy [J].
Litvan, I ;
Phipps, M ;
Pharr, VL ;
Hallett, M ;
Grafman, J ;
Salazar, A .
NEUROLOGY, 2001, 57 (03) :467-473
[10]   Corticobasal degeneration [J].
Mahapatra, RK ;
Edwards, MJ ;
Schott, JM ;
Bhatia, KP .
LANCET NEUROLOGY, 2004, 3 (12) :736-743